Vox Markets Logo

FTSE 100 movers: Melrose jumps on Citi note; Schroders tumbles on results

16:10, 5th November 2024

London's FTSE 100 was down 0.1% at 8,175.75 in afternoon trade on Tuesday.

Melrose was the standout gainer as Citi said it remains "high conviction" in the 'buy' case, citing the trough multiple and the strong mid-term cash outlook.

United Utilities and Severn Trent were both higher on the back of positive broker notes from Citi and JPMorgan Cazenove ahead of Ofwat's Final Determinations next month.

Citi upgraded United Utilities to 'buy', saying it was the best way to gain exposure ahead of Ofwat's regulatory review. It also upgraded SVT to 'neutral'.

Meanwhile, JPM lifted Severn Trent to 'overweight' from 'neutral', saying the premium to the sector is justified given its expectations of RCV growth and future outperformance, underpinned by the "best-in-class track record".

It maintained its 'overweight' rating on UU, saying it sees upside on conservative assumptions for outperformance in the next regulatory period, with upside risk to growth at FD.

Asset manager Schroders tumbled as it reported net outflows of £2.3bn for the third quarter.

FTSE 100 - Risers

Melrose Industries (MRO) 493.90p 4.15%
3i Group (III) 3,307.00p 3.31%
BT Group (BT.A) 146.25p 2.88%
United Utilities Group (UU.) 1,053.50p 2.58%
Severn Trent (SVT) 2,627.00p 2.22%
Pearson (PSON) 1,177.50p 1.86%
Rentokil Initial (RTO) 393.20p 1.81%
BAE Systems (BA.) 1,266.00p 1.73%
Next (NXT) 10,045.00p 1.65%
Intertek Group (ITRK) 4,740.00p 1.54%

FTSE 100 - Fallers

Schroders (SDR) 315.00p -13.37%
AstraZeneca (AZN) 10,288.00p -6.83%
Spirax Group (SPX) 6,425.00p -1.91%
GSK (GSK) 1,391.00p -1.63%
Hikma Pharmaceuticals (HIK) 1,826.00p -1.62%
Flutter Entertainment (DI) (FLTR) 17,455.00p -1.55%
Croda International (CRDA) 3,706.00p -1.51%
Pershing Square Holdings Ltd NPV (PSH) 3,430.00p -1.15%
Land Securities Group (LAND) 597.50p -0.99%
Haleon (HLN) 368.20p -0.97%

TwitterFacebookLinkedIn

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Watchlist